World's Best Scientists 2026 revealed!
Award Badge
Immunology
USA
2026

D-Index & Metrics

Immunology

D-Index
156
Citations
107851
World Ranking
97
National Ranking
61

Medicine

D-Index
156
Citations
107957
World Ranking
907
National Ranking
513

Ralph S. Baric publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ralph S. Baric sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 529 publications — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Ralph S. Baric D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ralph S. Baric sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 156 D-Index — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in United States Leader Award
  • 2025 - Research.com Immunology in United States Leader Award

Overview

Ralph S. Baric is affiliated with the University of North Carolina at Chapel Hill in the United States. Their research focuses primarily on Medicine, with extensive work in Infectious Diseases, Animal Science and Zoology, Epidemiology, Molecular Biology, and Immunology.

The scientist's main topics of research include:

  • SARS-CoV-2 and COVID-19 Research
  • Animal Virus Infections Studies
  • Viral gastroenteritis research and epidemiology
  • COVID-19 Clinical Research Studies
  • Respiratory viral infections research
  • Mosquito-borne diseases and control
  • Virus-based gene therapy research

Frequent co-authors working alongside Ralph S. Baric include:

  • Sarah R. Leist
  • Alexandra Schäfer
  • Boyd L. Yount
  • David R. Martinez
  • Timothy P. Sheahan

Their research is often published in venues such as UNC Libraries, bioRxiv (Cold Spring Harbor Laboratory), Science Translational Medicine, Nature Communications, and Nature.

Notable recent papers are:

  • "The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2" (2020), Nature Microbiology
  • "Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus" (2020), Journal of Virology
  • "Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity" (2020), Cell
  • "Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV" (2020), Nature Communications
  • "SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract" (2020), Cell

Best Publications

  • The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

    Alexander E. Gorbalenya;Susan C. Baker;Ralph S. Baric;Raoul J. de Groot

  • Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.

    Yushun Wan;Jian Shang;Rachel Graham;Ralph S. Baric

  • Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking

    Mingxun Wang;Jeremy J Carver;Vanessa V Phelan;Laura M Sanchez

  • Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV.

    Timothy P. Sheahan;Amy C. Sims;Sarah R. Leist;Alexandra Schäfer

  • Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group

    Alexander E. Gorbalenya;Alexander E. Gorbalenya;Susan C. Baker;Ralph Baric;Raoul J. de Groot

  • Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity.

    Carolyn Rydyznski Moderbacher;Sydney I. Ramirez;Sydney I. Ramirez;Jennifer M. Dan;Jennifer M. Dan;Alba Grifoni

  • Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses

    Timothy P. Sheahan;Amy C. Sims;Rachel L. Graham;Vineet D. Menachery

  • SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract.

    Yixuan J. Hou;Kenichi Okuda;Caitlin E. Edwards;David R. Martinez

  • SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness.

    Kizzmekia S. Corbett;Darin K. Edwards;Sarah R. Leist;Olubukola M. Abiona

  • Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group.

    Raoul J. de Groot;Susan C. Baker;Ralph S. Baric;Caroline S. Brown

  • Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.

    Evan J. Anderson;Nadine G. Rouphael;Alicia T. Widge;Lisa A. Jackson

  • Norwalk Virus: How Infectious Is It?

    Peter F.M. Teunis;Christine L. Moe;Pengbo Liu;Sara E. Miller

  • Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease

    Maria L. Agostini;Erica L. Andres;Amy C Sims;Rachel Lauren Graham

  • Human susceptibility and resistance to Norwalk virus infection

    Lisa Lindesmith;Christine Moe;Severine Marionneau;Nathalie Ruvoen

  • Potently neutralizing and protective human antibodies against SARS-CoV-2.

    Seth J. Zost;Pavlo Gilchuk;James Brett Case;Elad Binshtein

  • A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence

    Vineet D. Menachery;Boyd L. Yount;Kari Debbink;Sudhakar Agnihothram

  • Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.

    Kizzmekia S Corbett;Barbara Flynn;Kathryn E Foulds;Joseph R Francica

  • An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice.

    Timothy P. Sheahan;Amy C. Sims;Shuntai Zhou;Rachel L. Graham

  • DNA vaccine protection against SARS-CoV-2 in rhesus macaques.

    Jingyou Yu;Lisa H. Tostanoski;Lauren Peter;Noe B. Mercado

  • Zn2+ inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture

    Aartjan J. W. te Velthuis;Sjoerd H. E. van den Worm;Amy C. Sims;Ralph S. Baric

Frequent Co-Authors

Boyd Yount
Boyd Yount University of North Carolina at Chapel Hill
Lisa E. Gralinski
Lisa E. Gralinski University of North Carolina at Chapel Hill
Vineet D. Menachery
Vineet D. Menachery The University of Texas Medical Branch at Galveston
Amy C. Sims
Amy C. Sims University of North Carolina at Chapel Hill
Eric F. Donaldson
Eric F. Donaldson Center for Drug Evaluation and Research
Timothy P. Sheahan
Timothy P. Sheahan University of North Carolina at Chapel Hill
Alexandra Schäfer
Alexandra Schäfer Duke University
Mark T. Heise
Mark T. Heise University of North Carolina at Chapel Hill
David R. Martinez
David R. Martinez Yale University
Mark R. Denison
Mark R. Denison Vanderbilt University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding your qualifications in healthcare can open diverse career pathways. Many students pursue nursing degrees online to build a strong clinical foundation. Accelerated options are especially popular for those with prior experience in related fields.

Programs like the nurse practitioner accelerated program offer a fast track to advanced practice roles, combining rigorous coursework with hands-on training. These programs prepare graduates for roles that intersect closely with immunological research and patient care.

For individuals without a nursing background, the 12-month accelerated nursing programs online for non nurses provide an efficient pathway to enter the nursing field. The accelerated format allows for quicker transition into immunology-related clinical roles.

Students seeking accessible nursing programs can explore the easiest accelerated nursing programs or even lpn schools easy to get into. These programs emphasize streamlined admissions and practical training, providing foundational skills relevant to immunology careers in healthcare settings.

Best Scientists Citing Ralph S. Baric

Trending Scientists

Recently Published Articles